Rosopatamab
Catalogue number:
HY-P99239-5mg
Supplier:
Size:
5 mg
Product is available in:
Applications:
Cancer-programmed cell death
Target:
PSMA;Radionuclide-Drug Conjugates (RDCs)
Alternative Names:
HUJ-591; TLX591
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Rosopatamab (HuJ591) is a humanized antiPSMA IgG1 monoclonal antibody that can be used in cancer research, especially prostate cancer. Rosopatamab can be linked to the low-energy beta-emitting radioisotope lutetium-177 (177Lu) through the bifunctional chelator DOTA-NHS ester to obtain a radioimmunoconjugate that targets malignant prostate cells with high efficiency[1].